Davies Peter Miles Winston bought NEUP
January 20, 2026 · Form 4 insider transaction
Davies Peter Miles Winston bought 8,537 shares of Neuphoria Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.; The grant of RSUs is pursuant to the Company's Board of Directors annual remuneration policy.; Subject to the Reporting Person's continuous service to the Company through the first of the following dates: (a) the day prior to the Company' next annual shareholder meeting (which is expected to be no later than December 15, 2026) or (b) the effective date of a Change in Control of the Company, the RSUs shall fully vest.